The upregulated RPS1 binds to RPL11, thereby attenuating RPL11-MDM2-p53 signaling, which conversely facilitates the ubiquitination and degradation of p53 mediated by MDM2, ultimately propelling the progression of HCC [57]. The gene discussed is TP53; the disease is hepatocellular carcinoma.